Kyungki-do, South Korea

Young-Ger Suh

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young-Ger Suh: Innovator in Pharmaceutical Modulators

Introduction

Young-Ger Suh is a prominent inventor based in Kyungki-do, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of modulators for interleukin-1 and tumor necrosis factor-alpha. Her work focuses on creating chemical compounds that can be utilized in treating various diseases.

Latest Patents

Young-Ger Suh holds a patent for "Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators." This patent describes novel chemical compounds and pharmaceutical compositions that are useful in treating a range of diseases, including inflammation, cancer, and cardiovascular diseases. The patent also outlines methods for synthesizing these compounds, which can lead to advancements in medical treatments.

Career Highlights

Throughout her career, Young-Ger Suh has worked with notable organizations, including Nereus Pharmaceuticals, Inc. and the University of California. Her experience in these institutions has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Michael A. Palladino and Emmanuel A. Theodorakis. Their collaborative efforts have furthered the understanding and development of pharmaceutical compounds.

Conclusion

Young-Ger Suh's innovative work in the field of pharmaceutical modulators has the potential to impact the treatment of various diseases significantly. Her contributions to science and medicine exemplify the importance of research and development in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…